SlideShare a Scribd company logo
PHAGE THERAPY AN ALTERNATIVE TO
ANTIBIOTICS IN THE AGE OF MULTI DRUG
RESISTANCE
MUHAMMAD IQBAL
M.PHIL. MICROBIOLOGY
2ND SEMESTER
2014-GCUF-03745
Contents
 Introduction to Antibiotic Resistance
 Phage Therapy
 Introduction
 History
 Prep of phage
 Mechanism of Action
 Examples
 Phage vs Antibiotics
 Challenges
Antibiotics Resistance
 The ability of bacteria and other
microorganisms to resist the effects of
an antibiotic to which they were once
sensitive.
 Antibiotics resistance is mostly
developed due to
 Use and misuse of antibiotics
 Genetic variations and mutations in
bacteria causing disease.(Gulberg E et
al.,2011)
Bacteriophage
 viruses that only infect bacteria
and attack only a single
bacterial strains.
 This specificity together with
the killing capacity makes them
the natural enemies of bacteria
Life cycle of bacteriophage
Phage therapy
 Use of bacteriophage to treat pathogenic
bacterial infection
 Using phages or their products as bio-
agents for the treatment or prophylaxis of
bacterial infectious disease
History
 French Canadian microbiologist
Felix d’Herelle, first observed in
1910 the bacteriophage
phenomenon
 In 1917 he began testing his
phages in human patients
administration them to a 12 year
old boy with severe dysentery
resulting in complete recovery.
Cont.…
 First administration of phages was given in 1921 at the
hospital in Paris.
 In 1945 Phage therapy was abandoned in the Western world,
but maintained on a large scale in Poland and the USSR
where infections continued being successfully treated.(Derek
et al .2017)
Historical Medical Uses of Phage
Therapy
 Anthrax
 Cholera
 Dysentry
 Gonorrhea
 Meningitis
 Tuberculosis
 Typhoid fever etc….. (Xavier et al .,2014)
Where we can find Phages?
 In Human and Animals Intestine
 In Running Water
 In the soil
 Sewage from corpses
Spot test
Middle broke top Agar (jiffy et al., 2015)
Mode of action
Lytic Cycle
Engineered nonlytic antibacterial
phage
 Temperate phage engineered to deliver synthetic gene network
 undergo a latent lifecycle after infection, called lysogeny. Here, the viral
genome integrates into the bacterium's chromosome as a prophage.
 where it can express antimicrobial proteins (AMPs) that interfere with
intracellular processes and cause bacterial death .
Cont…..
 Phagemids can also deliver synthetic gene network on a
synthetic plasmid
 that encode for antibacterial proteins, such encoding a RNA-
guided CRISPR-associated (Cas) nucleases
 for sequence-specific nonlytic bacterial death
 and plasmid removal.
 Phagemid plasmids can also encode for AMPs (Thiel et
al.,2004).
Killing of Mycobacterium avium and M.tuberculosis by a
Mycobacteriophage Delivered by a Nonvirulent
Mycobacterium
 Tuberculosis is a serious public health problem that results in
millions of deaths around the world each year
 Mycobacterium smegmatis, an avirulent mycobacterium, is
used to deliver the lytic phage TM4 where both M. avium
and M. tuberculosis reside within macrophages
 These results showed that treatment of M. avium–
infected, as well as M. tuberculosis infected, RAW
264.7 macrophages, with M. smegmatis transiently
infected with TM4, resulted in a significant time and
titer-dependent reduction in the number of viable
intracellular bacilli( Lia et al.,2006).
Experimental phage therapy against
S.aureus in mice
 This study describes a bacteriophage active against
Staphylococcus aureus, including methicillin-resistant
staphylococcal strains.
 When inoculated into mice simultaneously with S.
aureus (108 CFU/mouse), then 97% of the mice
recovered(Koen et al., 2015).
Current status of human phage
therapy
 Still phage therapy Approved in
 Russia
 Poland
 Georgia
Bacteriophage vs Antibiotics
 Very specific
 Abundant in environment
 no side effects have been
reported
 Replicate at the site of infection
 Good alternative for patients
allergic to antibodies
 Their action is bactericidal
 Target normal flora and
pathogens
 Have sever side effects like
allergies and secondary infection
 Have sever side effects like
allergies and secondary infection
 If patient is allergic to antibiotic,
treatment is very difficult
 Some are bacteriostatic
Challenges
 Host Range
 Bacterial Debries present in the phage preparation
 Antiphage Antibodies
References
 Broxmeyer L et al Killing of Mycobacterium avium and Mycobacterium
tuberculosis by a Mycobacteriophage Delivered by a Nonvirulent
Mycobacterium: AModel for Phage Therapy of Intracellular Bacterial
Pathogens J Infect Dis 186: 1155-60
 Brussow H (2005) Phage therapy: the Escherichia coli experience Microbiol
151:2133-40 Carlton R M (1999) Phage therapy: Past history and Future
prospects Arch Immunol Ther Exp 47: 267-74
 Haq I U et al (2012) Bacteriophages and their Implications on Future
Biotechnology:A Review J Virol 9.
 Inal J M (2003) Phage Therapy: a Reappraisal of Bacteriophages as
Antibiotics Arch Immunol Ther Exp 51:237-44
Cont…..
 Skurnik M and Strauch E (2006) Phage therapy: Facts and Fiction Int J Med
Microbiol 296 :5-14
 Sulakvelidze A (2011) The Challenges of Bacteriophage Therapy Eur I
Pharm 10:14-18
 Thiel K (2004) Old dogma, new tricks—21st Century phage therapy Nat
Biotechnol 22:31-36

More Related Content

What's hot

Phage therapy
Phage therapyPhage therapy
Phage therapy
Fatma Faris
 
Phage Therapy.pptx
Phage Therapy.pptxPhage Therapy.pptx
Phage Therapy.pptx
RohailBhatti2
 
Virus host interactions
Virus host interactionsVirus host interactions
Virus host interactionsraghunathp
 
Bacteriocin
BacteriocinBacteriocin
Bacteriocin
Marwa A. Al-Asady
 
Vaccine Production
Vaccine Production Vaccine Production
Vaccine Production
NilambarKhura
 
Recombinant vaccine
Recombinant vaccineRecombinant vaccine
Recombinant vaccine
Dr NEETHU ASOKAN
 
Viral vaccines, An introduction
Viral vaccines, An introduction Viral vaccines, An introduction
Viral vaccines, An introduction
Kaveh Haratian
 
Vaccine production
Vaccine productionVaccine production
Vaccine production
Shweta Tiwari
 
Bacteriophage
BacteriophageBacteriophage
Bacteriophage
niranjay
 
Vector vacccine
Vector vacccineVector vacccine
Vector vacccine
DUVASU
 
Antiviral agents and sensitivity tests
Antiviral agents and sensitivity testsAntiviral agents and sensitivity tests
Antiviral agents and sensitivity tests
Abhijit Chaudhury
 
host and virus interaction
host and virus interactionhost and virus interaction
Bacteriocins
BacteriocinsBacteriocins
Bacteriocins
Kumuda J
 
Bacteriophages & Its classification, cycles, therapy, and applications
Bacteriophages & Its classification, cycles, therapy, and applicationsBacteriophages & Its classification, cycles, therapy, and applications
Bacteriophages & Its classification, cycles, therapy, and applications
ZoqiaTariq
 
History of the Forgotten Cure - Phage therapy
History of the Forgotten Cure - Phage therapyHistory of the Forgotten Cure - Phage therapy
History of the Forgotten Cure - Phage therapy
Student
 
Mechanism of pathogenicity-Exotoxin and endotoxin
Mechanism of pathogenicity-Exotoxin and endotoxinMechanism of pathogenicity-Exotoxin and endotoxin
Mechanism of pathogenicity-Exotoxin and endotoxin
aiswarya thomas
 
M13 and Mu Virus Structure and Life Cycle
M13 and Mu Virus Structure and Life CycleM13 and Mu Virus Structure and Life Cycle
M13 and Mu Virus Structure and Life Cycle
ShashankPatil54
 
Phage typing
Phage typingPhage typing
Phage typing
siva ni
 
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...kamal shrestha
 

What's hot (20)

Phage therapy
Phage therapyPhage therapy
Phage therapy
 
Phage Therapy.pptx
Phage Therapy.pptxPhage Therapy.pptx
Phage Therapy.pptx
 
Virus host interactions
Virus host interactionsVirus host interactions
Virus host interactions
 
Bacteriocin
BacteriocinBacteriocin
Bacteriocin
 
Vaccine Production
Vaccine Production Vaccine Production
Vaccine Production
 
Recombinant vaccine
Recombinant vaccineRecombinant vaccine
Recombinant vaccine
 
Viral vaccines, An introduction
Viral vaccines, An introduction Viral vaccines, An introduction
Viral vaccines, An introduction
 
Vaccine production
Vaccine productionVaccine production
Vaccine production
 
Bacteriophage
BacteriophageBacteriophage
Bacteriophage
 
Vector vacccine
Vector vacccineVector vacccine
Vector vacccine
 
Antiviral agents and sensitivity tests
Antiviral agents and sensitivity testsAntiviral agents and sensitivity tests
Antiviral agents and sensitivity tests
 
host and virus interaction
host and virus interactionhost and virus interaction
host and virus interaction
 
Bacteriocins
BacteriocinsBacteriocins
Bacteriocins
 
Bacteriophages & Its classification, cycles, therapy, and applications
Bacteriophages & Its classification, cycles, therapy, and applicationsBacteriophages & Its classification, cycles, therapy, and applications
Bacteriophages & Its classification, cycles, therapy, and applications
 
bacteriophage
bacteriophage bacteriophage
bacteriophage
 
History of the Forgotten Cure - Phage therapy
History of the Forgotten Cure - Phage therapyHistory of the Forgotten Cure - Phage therapy
History of the Forgotten Cure - Phage therapy
 
Mechanism of pathogenicity-Exotoxin and endotoxin
Mechanism of pathogenicity-Exotoxin and endotoxinMechanism of pathogenicity-Exotoxin and endotoxin
Mechanism of pathogenicity-Exotoxin and endotoxin
 
M13 and Mu Virus Structure and Life Cycle
M13 and Mu Virus Structure and Life CycleM13 and Mu Virus Structure and Life Cycle
M13 and Mu Virus Structure and Life Cycle
 
Phage typing
Phage typingPhage typing
Phage typing
 
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
Bacteriophage therapy for antimicrobial resistant and biofilm forming [Autosa...
 

Similar to Phage therapy

Peace seminar 2222
Peace seminar 2222Peace seminar 2222
Peace seminar 2222Elvis Ogbe
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ Fawcett
Nicola Fawcett
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
Unit 3. chemotherapy
Unit 3. chemotherapyUnit 3. chemotherapy
Unit 3. chemotherapy
MirzaAnwarBaig1
 
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdfSyngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon
 
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
Mirza Anwar Baig
 
Bacteriophages come in different sizes and shapes but most of them.docx
Bacteriophages come in different sizes and shapes but most of them.docxBacteriophages come in different sizes and shapes but most of them.docx
Bacteriophages come in different sizes and shapes but most of them.docx
rock73
 
Antibiotic Resistant Bacteria
Antibiotic Resistant BacteriaAntibiotic Resistant Bacteria
Antibiotic Resistant Bacteria
Kevin B Hugins
 
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Cassandra Quave
 
Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...
Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...
Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...
Healthcare and Medical Sciences
 
Phage therapy in the 21st century
Phage therapy in the 21st centuryPhage therapy in the 21st century
Phage therapy in the 21st century
VenusTupate
 
edible vaccine
edible vaccineedible vaccine
edible vaccine
Rekha Kumari
 
AMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - MicrobiologyAMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - Microbiology
Sijo A
 
Immunology and Microbiology,Host-Microbe Interactions
Immunology and Microbiology,Host-Microbe InteractionsImmunology and Microbiology,Host-Microbe Interactions
Immunology and Microbiology,Host-Microbe Interactions
varinder kumar
 
Monoclonal antibody, history, development and progress
Monoclonal antibody, history, development and progressMonoclonal antibody, history, development and progress
Monoclonal antibody, history, development and progress
Radhika Hegde
 
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptxBIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
Alok Kumar
 
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
iosrjce
 

Similar to Phage therapy (20)

Peace seminar 2222
Peace seminar 2222Peace seminar 2222
Peace seminar 2222
 
Microbiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ FawcettMicrobiome & Infection Control - NJ Fawcett
Microbiome & Infection Control - NJ Fawcett
 
Pseudomonas Aeruginosa
Pseudomonas AeruginosaPseudomonas Aeruginosa
Pseudomonas Aeruginosa
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
Unit 3. chemotherapy
Unit 3. chemotherapyUnit 3. chemotherapy
Unit 3. chemotherapy
 
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdfSyngulon - Breakout session Synthetic Biology June 10, 2022.pdf
Syngulon - Breakout session Synthetic Biology June 10, 2022.pdf
 
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
6. introduction to chemotherapy, sulfonamides,quinolones and fluoroquinolones
 
Bacteriophages come in different sizes and shapes but most of them.docx
Bacteriophages come in different sizes and shapes but most of them.docxBacteriophages come in different sizes and shapes but most of them.docx
Bacteriophages come in different sizes and shapes but most of them.docx
 
Antibiotic Resistant Bacteria
Antibiotic Resistant BacteriaAntibiotic Resistant Bacteria
Antibiotic Resistant Bacteria
 
Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015Alan Lesniewicz Memorial Lecture at UIC - July 2015
Alan Lesniewicz Memorial Lecture at UIC - July 2015
 
Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...
Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...
Current Antibiotic Resistance Trends of Uropathogens from Outpatients in a Ni...
 
Phage therapy in the 21st century
Phage therapy in the 21st centuryPhage therapy in the 21st century
Phage therapy in the 21st century
 
edible vaccine
edible vaccineedible vaccine
edible vaccine
 
AMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - MicrobiologyAMR & Alternative Stratergies - Microbiology
AMR & Alternative Stratergies - Microbiology
 
Immunology and Microbiology,Host-Microbe Interactions
Immunology and Microbiology,Host-Microbe InteractionsImmunology and Microbiology,Host-Microbe Interactions
Immunology and Microbiology,Host-Microbe Interactions
 
Bruno pot
Bruno pot Bruno pot
Bruno pot
 
Monoclonal antibody, history, development and progress
Monoclonal antibody, history, development and progressMonoclonal antibody, history, development and progress
Monoclonal antibody, history, development and progress
 
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptxBIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
BIOTECHNOLOGY 3RD ICA ASSIGNMENT BY ALOK KUMAR.pptx
 
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
Prevalence and Characterisation of Beta Lactamases in Multi Drug Resistant Gr...
 

More from Muhammad iqbal

Tuberculosis
TuberculosisTuberculosis
Tuberculosis
Muhammad iqbal
 
Complement & complement system
Complement & complement systemComplement & complement system
Complement & complement system
Muhammad iqbal
 
Fermentation of bakery products
Fermentation of bakery productsFermentation of bakery products
Fermentation of bakery products
Muhammad iqbal
 
Presentation of elisa test
Presentation of elisa testPresentation of elisa test
Presentation of elisa test
Muhammad iqbal
 
Biofilms
BiofilmsBiofilms
Biofilms
Muhammad iqbal
 
Causes of cancer
Causes of cancerCauses of cancer
Causes of cancer
Muhammad iqbal
 
Metastasis
MetastasisMetastasis
Metastasis
Muhammad iqbal
 
Cancer presentation
Cancer presentationCancer presentation
Cancer presentation
Muhammad iqbal
 
Pro and prebiotics
Pro and prebioticsPro and prebiotics
Pro and prebiotics
Muhammad iqbal
 
Role of bacterial organelles in virulence
Role of bacterial organelles in virulenceRole of bacterial organelles in virulence
Role of bacterial organelles in virulence
Muhammad iqbal
 
Bacterial structures and their functions
Bacterial structures and their functionsBacterial structures and their functions
Bacterial structures and their functions
Muhammad iqbal
 
Bacillus
BacillusBacillus
Bacillus
Muhammad iqbal
 
Staining
StainingStaining
Staining
Muhammad iqbal
 
Detection of Cryptospordium
Detection of CryptospordiumDetection of Cryptospordium
Detection of Cryptospordium
Muhammad iqbal
 
Human papilloma virus
Human papilloma virusHuman papilloma virus
Human papilloma virus
Muhammad iqbal
 
Fermentation of vineger
Fermentation of vinegerFermentation of vineger
Fermentation of vineger
Muhammad iqbal
 
Dna vaccine
Dna vaccineDna vaccine
Dna vaccine
Muhammad iqbal
 
Cancer vaccine
Cancer vaccineCancer vaccine
Cancer vaccine
Muhammad iqbal
 
Polio vaccine
Polio vaccinePolio vaccine
Polio vaccine
Muhammad iqbal
 
Hcv vaccine
Hcv vaccineHcv vaccine
Hcv vaccine
Muhammad iqbal
 

More from Muhammad iqbal (20)

Tuberculosis
TuberculosisTuberculosis
Tuberculosis
 
Complement & complement system
Complement & complement systemComplement & complement system
Complement & complement system
 
Fermentation of bakery products
Fermentation of bakery productsFermentation of bakery products
Fermentation of bakery products
 
Presentation of elisa test
Presentation of elisa testPresentation of elisa test
Presentation of elisa test
 
Biofilms
BiofilmsBiofilms
Biofilms
 
Causes of cancer
Causes of cancerCauses of cancer
Causes of cancer
 
Metastasis
MetastasisMetastasis
Metastasis
 
Cancer presentation
Cancer presentationCancer presentation
Cancer presentation
 
Pro and prebiotics
Pro and prebioticsPro and prebiotics
Pro and prebiotics
 
Role of bacterial organelles in virulence
Role of bacterial organelles in virulenceRole of bacterial organelles in virulence
Role of bacterial organelles in virulence
 
Bacterial structures and their functions
Bacterial structures and their functionsBacterial structures and their functions
Bacterial structures and their functions
 
Bacillus
BacillusBacillus
Bacillus
 
Staining
StainingStaining
Staining
 
Detection of Cryptospordium
Detection of CryptospordiumDetection of Cryptospordium
Detection of Cryptospordium
 
Human papilloma virus
Human papilloma virusHuman papilloma virus
Human papilloma virus
 
Fermentation of vineger
Fermentation of vinegerFermentation of vineger
Fermentation of vineger
 
Dna vaccine
Dna vaccineDna vaccine
Dna vaccine
 
Cancer vaccine
Cancer vaccineCancer vaccine
Cancer vaccine
 
Polio vaccine
Polio vaccinePolio vaccine
Polio vaccine
 
Hcv vaccine
Hcv vaccineHcv vaccine
Hcv vaccine
 

Recently uploaded

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
Jean Carlos Nunes Paixão
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
AyyanKhan40
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
ArianaBusciglio
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
TechSoup
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
amberjdewit93
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Akanksha trivedi rama nursing college kanpur.
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
Priyankaranawat4
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
Nguyen Thanh Tu Collection
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
Bisnar Chase Personal Injury Attorneys
 

Recently uploaded (20)

Lapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdfLapbook sobre os Regimes Totalitários.pdf
Lapbook sobre os Regimes Totalitários.pdf
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
PIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf IslamabadPIMS Job Advertisement 2024.pdf Islamabad
PIMS Job Advertisement 2024.pdf Islamabad
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Group Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana BuscigliopptxGroup Presentation 2 Economics.Ariana Buscigliopptx
Group Presentation 2 Economics.Ariana Buscigliopptx
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat  Leveraging AI for Diversity, Equity, and InclusionExecutive Directors Chat  Leveraging AI for Diversity, Equity, and Inclusion
Executive Directors Chat Leveraging AI for Diversity, Equity, and Inclusion
 
Digital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental DesignDigital Artefact 1 - Tiny Home Environmental Design
Digital Artefact 1 - Tiny Home Environmental Design
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama UniversityNatural birth techniques - Mrs.Akanksha Trivedi Rama University
Natural birth techniques - Mrs.Akanksha Trivedi Rama University
 
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdfANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
ANATOMY AND BIOMECHANICS OF HIP JOINT.pdf
 
Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.Biological Screening of Herbal Drugs in detailed.
Biological Screening of Herbal Drugs in detailed.
 
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
BÀI TẬP BỔ TRỢ TIẾNG ANH GLOBAL SUCCESS LỚP 3 - CẢ NĂM (CÓ FILE NGHE VÀ ĐÁP Á...
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
 

Phage therapy

  • 1. PHAGE THERAPY AN ALTERNATIVE TO ANTIBIOTICS IN THE AGE OF MULTI DRUG RESISTANCE MUHAMMAD IQBAL M.PHIL. MICROBIOLOGY 2ND SEMESTER 2014-GCUF-03745
  • 2. Contents  Introduction to Antibiotic Resistance  Phage Therapy  Introduction  History  Prep of phage  Mechanism of Action  Examples  Phage vs Antibiotics  Challenges
  • 3. Antibiotics Resistance  The ability of bacteria and other microorganisms to resist the effects of an antibiotic to which they were once sensitive.  Antibiotics resistance is mostly developed due to  Use and misuse of antibiotics  Genetic variations and mutations in bacteria causing disease.(Gulberg E et al.,2011)
  • 4.
  • 5. Bacteriophage  viruses that only infect bacteria and attack only a single bacterial strains.  This specificity together with the killing capacity makes them the natural enemies of bacteria
  • 6. Life cycle of bacteriophage
  • 7. Phage therapy  Use of bacteriophage to treat pathogenic bacterial infection  Using phages or their products as bio- agents for the treatment or prophylaxis of bacterial infectious disease
  • 8. History  French Canadian microbiologist Felix d’Herelle, first observed in 1910 the bacteriophage phenomenon  In 1917 he began testing his phages in human patients administration them to a 12 year old boy with severe dysentery resulting in complete recovery.
  • 9. Cont.…  First administration of phages was given in 1921 at the hospital in Paris.  In 1945 Phage therapy was abandoned in the Western world, but maintained on a large scale in Poland and the USSR where infections continued being successfully treated.(Derek et al .2017)
  • 10. Historical Medical Uses of Phage Therapy  Anthrax  Cholera  Dysentry  Gonorrhea  Meningitis  Tuberculosis  Typhoid fever etc….. (Xavier et al .,2014)
  • 11. Where we can find Phages?  In Human and Animals Intestine  In Running Water  In the soil  Sewage from corpses
  • 12.
  • 13.
  • 14. Spot test Middle broke top Agar (jiffy et al., 2015)
  • 16. Engineered nonlytic antibacterial phage  Temperate phage engineered to deliver synthetic gene network  undergo a latent lifecycle after infection, called lysogeny. Here, the viral genome integrates into the bacterium's chromosome as a prophage.  where it can express antimicrobial proteins (AMPs) that interfere with intracellular processes and cause bacterial death .
  • 17. Cont…..  Phagemids can also deliver synthetic gene network on a synthetic plasmid  that encode for antibacterial proteins, such encoding a RNA- guided CRISPR-associated (Cas) nucleases  for sequence-specific nonlytic bacterial death  and plasmid removal.  Phagemid plasmids can also encode for AMPs (Thiel et al.,2004).
  • 18.
  • 19. Killing of Mycobacterium avium and M.tuberculosis by a Mycobacteriophage Delivered by a Nonvirulent Mycobacterium  Tuberculosis is a serious public health problem that results in millions of deaths around the world each year  Mycobacterium smegmatis, an avirulent mycobacterium, is used to deliver the lytic phage TM4 where both M. avium and M. tuberculosis reside within macrophages
  • 20.  These results showed that treatment of M. avium– infected, as well as M. tuberculosis infected, RAW 264.7 macrophages, with M. smegmatis transiently infected with TM4, resulted in a significant time and titer-dependent reduction in the number of viable intracellular bacilli( Lia et al.,2006).
  • 21.
  • 22. Experimental phage therapy against S.aureus in mice  This study describes a bacteriophage active against Staphylococcus aureus, including methicillin-resistant staphylococcal strains.  When inoculated into mice simultaneously with S. aureus (108 CFU/mouse), then 97% of the mice recovered(Koen et al., 2015).
  • 23.
  • 24. Current status of human phage therapy  Still phage therapy Approved in  Russia  Poland  Georgia
  • 25. Bacteriophage vs Antibiotics  Very specific  Abundant in environment  no side effects have been reported  Replicate at the site of infection  Good alternative for patients allergic to antibodies  Their action is bactericidal  Target normal flora and pathogens  Have sever side effects like allergies and secondary infection  Have sever side effects like allergies and secondary infection  If patient is allergic to antibiotic, treatment is very difficult  Some are bacteriostatic
  • 26. Challenges  Host Range  Bacterial Debries present in the phage preparation  Antiphage Antibodies
  • 27. References  Broxmeyer L et al Killing of Mycobacterium avium and Mycobacterium tuberculosis by a Mycobacteriophage Delivered by a Nonvirulent Mycobacterium: AModel for Phage Therapy of Intracellular Bacterial Pathogens J Infect Dis 186: 1155-60  Brussow H (2005) Phage therapy: the Escherichia coli experience Microbiol 151:2133-40 Carlton R M (1999) Phage therapy: Past history and Future prospects Arch Immunol Ther Exp 47: 267-74  Haq I U et al (2012) Bacteriophages and their Implications on Future Biotechnology:A Review J Virol 9.  Inal J M (2003) Phage Therapy: a Reappraisal of Bacteriophages as Antibiotics Arch Immunol Ther Exp 51:237-44
  • 28. Cont…..  Skurnik M and Strauch E (2006) Phage therapy: Facts and Fiction Int J Med Microbiol 296 :5-14  Sulakvelidze A (2011) The Challenges of Bacteriophage Therapy Eur I Pharm 10:14-18  Thiel K (2004) Old dogma, new tricks—21st Century phage therapy Nat Biotechnol 22:31-36